ABVC BioPharma, Inc. Financing Receivable Before Allowance For Credit Loss To Total Percent
ABVC BioPharma, Inc. (ABVC) had Financing Receivable Before Allowance For Credit Loss To Total Percent of 87.24% as of 2024-03-31, per its 10-Q filed 2024-05-17.
Discontinued › Notes › Receivables
srt:FinancingReceivableBeforeAllowanceForCreditLossToTotalPercent · last filed 2024-05-17
- 2024-03-31: Financing Receivable Before Allowance For Credit Loss To Total Percent 87.24%.
- 2023-12-31: Financing Receivable Before Allowance For Credit Loss To Total Percent 87.24%.
| Period end | Financing Receivable Before Allowance For Credit Loss To Total Percent |
|---|---|
| 2024-03-31 | 87.24% 10-Q · filed 2024-05-17 |
| 2023-12-31 | 87.24% 10-Q · filed 2024-05-17 |